EW · Edwards Lifesciences Corp
United States · RS rating 84 · As of 2026-11-03
| Price | 95.19 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 81 / 79 / 64 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 45 / 30 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -68.0% |
| Sales growth Q/Q | +1.1% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $46.0B |